Abvc Biopharma, Inc.: Form DEF 14A, filed Mar 5, 2026
Filed with the SEC on Mar 5, 2026 and accepted by EDGAR at Mar 5, 2026, 16:29 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-26-024122. Last ingested by Listed: Nov 2, 2026, 09:52 ET. Listed shows no prices and gives no investment advice.